|
시장보고서
상품코드
2008748
측방유동 어세이 시장 보고서 : 기술별, 제품별, 용도별, 최종사용자별, 지역별(2026-2034년)Lateral Flow Assay Market Report by Technique, Product, Application, End User, and Region 2026-2034 |
||||||
세계의 측방유동 어세이 시장 규모는 2025년에 113억 달러에 달했습니다. 향후 IMARC Group은 2034년까지 시장 규모가 161억 달러에 달하며, 2026-2034년에 CAGR 4.00%로 성장할 것으로 예측하고 있습니다.
LFA(Lateral Flow Assay)는 복잡한 혼합물에서 분석 대상 물질을 검출 및 정량하는 종이 기반 플랫폼입니다. 타액, 소변, 땀, 혈청, 혈장, 혈액, 기타 체액과 같은 생물학적 검체 검사를 지원합니다. 그 결과, 특정 병원체, 항체 및 유전자 증폭의 정성 및 정량적 검출을 위해 병원 및 임상 실험실에서 널리 사용되고 있습니다. 또한 LFA는 생의학, 농업, 식품, 환경과학 분야에서 활용되는 저비용, 간편, 신속, 휴대가 가능한 검출 장비의 제조에도 기여하여 전 세계에서 큰 인기를 끌고 있습니다.
측방유동 어세이 시장 동향:
신종 코로나바이러스 감염증(COVID-19)의 확산으로 인해 환자의 검체를 검사실로 보내는 대신 사용할 수 있는 대체 수단에 대한 수요가 증가하고 있습니다. 또한 중합효소연쇄반응(PCR) 검사를 쉽게 수행할 수 있는 대규모 검사 시설과 숙련된 의료진의 부족은 시장 성장을 촉진하는 주요 요인 중 하나입니다. LFA 키트는 편리하고, 작고 휴대성이 뛰어나며, 최소한의 교육으로 조작이 가능합니다. 세척 공정, 냉장 보관, 전처리가 필요 없는 원스텝 분석으로 기능합니다. 또한 정성적 또는 반정량적 결과를 제공하는 신속한 검사 절차를 갖추고 있으며, 발색에 소요되는 시간이 비교적 짧고, 사전에 배치를 준비할 수 있습니다. 이와 더불어 효과적인 치료를 위해 새로운 진단법을 필요로 하는 감염증의 유병률이 증가하고 있습니다. 여기에 더해 감염증의 확산, 진단, 예방을 강화하기 위한 인식 개선 프로그램이 크게 증가하고 있는 것도 시장 성장에 기여하고 있습니다. 또한 주요 기업은 새로운 신호 강화 기술을 도입하여 정량화 시스템 및 동시 검출 기능을 개선하고 있으며, 이는 시장 전망을 좋게 만들고 있습니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 측방유동 어세이 시장
제6장 시장 내역 : 방법별
제7장 시장 내역 : 제품별
제8장 시장 내역 : 용도별
제9장 시장 내역 : 최종사용자별
제10장 시장 내역 : 지역별
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porter's Five Forces 분석
제14장 가격 분석
제15장 경쟁 구도
KSAThe global lateral flow assay market size reached USD 11.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 16.1 Billion by 2034, exhibiting a growth rate (CAGR) of 4.00% during 2026-2034.
Lateral flow assay (LFA) is a paper-based platform that detects and quantifies analytes in complex mixtures. It assists in testing biological samples of saliva, urine, sweat, serum, plasma, blood, and other fluids. As a result, it is widely employed in hospitals and clinical laboratories for the qualitative and quantitative detection of specific agents, antibodies, and gene amplification. Besides this, as it also aids in producing low-cost, simple, rapid, and portable detection devices that are utilized in biomedicine, agriculture, food, and environmental sciences, LFA is gaining immense popularity across the globe.
LATERAL FLOW ASSAY MARKET TRENDS:
Due to the coronavirus disease (COVID-19) outbreak, there is a rise in the need for an alternative of sending patient samples to the laboratory. This, in confluence with the lack of extensive laboratory facilities or trained health workers to easily conduct polymerase chain reaction (PCR) tests, represents one of the key factors bolstering the growth of the market. LFA kits are convenient, smaller, portable, and can be controlled with minimal training. They act as a one-step assay that does not require washing steps, refrigeration, and pretreatment. They also faster test procedures that offer qualitative or semi-quantitative results, take a relatively short time for development, and allow the preparation of batches in advance. Besides this, there is an increase in the prevalence of infectious diseases that require new diagnostic methods for effective treatment. This, along with the significantly rising awareness programs to enhance the spread of infections, diagnosis, and prevention, is contributing to market growth. Furthermore, leading players are introducing novel signal enhancement techniques and improving quantification systems and simultaneous detection, which is creating a favorable market outlook.
KEY MARKET SEGMENTATION:
Breakup by Technique:
- Sandwich Assays
- Competitive Assays
- Multiplex Detection Assays
Breakup by Product:
- Kits and Reagents
- Lateral Flow Readers
- Digital/Mobile Readers
- Benchtop Readers
Breakup by Application:
- Clinical Testing
- Infectious Disease Testing
- Cardiac Marker Testing
- Pregnancy and Fertility Testing
- Cholesterol Testing/Lipid Profile
- Drug Abuse Testing
- Others
- Veterinary Diagnostics
- Food Safety and Environment Testing
- Drug Development and Quality Testing
Breakup by End User:
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care
- Pharmaceutical and Biotechnology Companies
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Merck KGAA, Perkinelmer Inc., Qiagen N.V., Quidel Corporation, Siemens Healthineers AG (Siemens AG) and Thermo Fisher Scientific Inc.
KEY QUESTIONS ANSWERED IN THIS REPORT
1. How big is the global lateral flow assay market?
2. What is the expected growth rate of the global lateral flow assay market during 2026-2034?
3. What are the key factors driving the global lateral flow assay market?
4. What has been the impact of COVID-19 on the global lateral flow assay market?
5. What is the breakup of the global lateral flow assay market based on the technique?
6. What is the breakup of the global lateral flow assay market based on the product?
7. What is the breakup of the global lateral flow assay market based on the application?
8. What is the breakup of the global lateral flow assay market based on the end user?
9. What are the key regions in the global lateral flow assay market?
10. Who are the key players/companies in the global lateral flow assay market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Lateral Flow Assay Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Technique
- 6.1 Sandwich Assays
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Competitive Assays
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Multiplex Detection Assays
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Product
- 7.1 Kits and Reagents
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Lateral Flow Readers
- 7.2.1 Market Trends
- 7.2.2 Key Segments
- 7.2.2.1 Digital/Mobile Readers
- 7.2.2.2 Benchtop Readers
- 7.2.3 Market Forecast
8 Market Breakup by Application
- 8.1 Clinical Testing
- 8.1.1 Market Trends
- 8.1.2 Key Segments
- 8.1.2.1 Infectious Disease Testing
- 8.1.2.2 Cardiac Marker Testing
- 8.1.2.3 Pregnancy and Fertility Testing
- 8.1.2.4 Cholesterol Testing/Lipid Profile
- 8.1.2.5 Drug Abuse Testing
- 8.1.2.6 Others
- 8.1.3 Market Forecast
- 8.2 Veterinary Diagnostics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Food Safety and Environment Testing
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Drug Development and Quality Testing
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Diagnostic Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Home Care
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Pharmaceutical and Biotechnology Companies
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Others
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Becton Dickinson and Company
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Biomerieux SA
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Bio-Rad Laboratories Inc.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Danaher Corporation
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 F. Hoffmann-La Roche AG
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 SWOT Analysis
- 15.3.7 Hologic Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Merck KGAA
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Perkinelmer Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Qiagen N.V.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Quidel Corporation
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.12 Siemens Healthineers AG (Siemens AG)
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.13 Thermo Fisher Scientific Inc.
- 15.3.13.1 Company Overview
- 15.3.13.2 Product Portfolio
- 15.3.13.3 Financials
- 15.3.13.4 SWOT Analysis
- 15.3.1 Abbott Laboratories
